Category: news

February 10, 2026 Off

AstraZeneca results: FY and Q4 2025

By BusinessWire

Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period CAMBRIDGE, England–(BUSINESS WIRE)–AstraZeneca: Revenue and EPS summary  …